Skip to main content
. 2020 Jul 12;5(10):1811–1814. doi: 10.1016/j.ekir.2020.06.039

Table 1.

Teaching points

1. Hypoglycemia is a rare side effect of hydroxychloroquine.
2. Hydroxychloroquine dosage must be reduced in hemodialysis patients, even for short-term treatment protocols.
3. The optimal treatment of COVID-19 in patients with chronic kidney disease remains unknown.
4. New well-designed and qualified trials for the treatment of COVID-19 are needed.

COVID-19, coronavirus disease 2019.